Chief Sales and Customer Officer of Curation · Lifecore Biomedical, Inc. (LFCR)

Parker Javid

FY2019 is the first fiscal year CompBrief holds for Parker Javid as a named executive officer of Lifecore Biomedical; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2019

$460,691

Salary $283,000Stock awards $100,144

6th of 6 named executive officers at Lifecore Biomedical by FY2019 total.

6 named officers on file for Lifecore Biomedical, FY2019

Parker Javid’s pay file — $29

  • 1 fiscal year of pay, line by line
  • 3 equity grants, each cited to its filing
  • LFCR’s disclosed peer group of 20 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Lifecore Biomedical’s whole pay program stands against its peers

  • Lifecore Biomedical’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on LFCR→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed August 21, 2019 (DEF 14A).

Free

Get Parker Javid’s full pay file as a PDF — free

More than this page: up to 10 years of Parker’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Parker Javid compensation by year

Lifecore Biomedical Summary Compensation Table · the one fiscal year held
In US dollars, as Lifecore Biomedical reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2019
Salary$283,000
Bonus$0
Stock awards$100,144
Option awards$38,639
Non-equity incentive$25,968
Pension and deferred compensation$0
All other$12,940
Total$460,691

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Lifecore Biomedical, Inc. DEF 14A filed August 21, 2019, accession 0001628280-19-011060, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Lifecore Biomedical, Inc. filed document, accession 0001628280-19-011060. Every figure is read from that document and cited to the page and table it appears in. Filed August 21, 2019.

Equity holdings

unvested awards at FY2019 year-end
TypeUnvested unitsValue at year-endExercise price
RSU5,000$47,100—
RSU3,750$35,325—
RSU3,631$34,204—
Option8,125—$14.35
Option7,084—$12.65

Per the Outstanding Equity Awards at Fiscal Year-End table in Lifecore Biomedical, Inc.'s FY2019 proxy; value at the fiscal year-end close, as the company printed it.

Lifecore Biomedical’s named executive officers, FY2019

as the company reported each
Named executive officerRoleFY2019 total
Molly HemmeterFormer President and Chief Executive Officer$1,756,105
Albert BollesPresident and Chief Executive Officer$1,004,966
Gregory SkinnerExecutive Vice President of Finance and Administration and Chief Financial Officer$845,951
James HallPresident of Lifecore and Vice President of Landec$824,469
Brian McLaughlinChief Financial Officer$482,986
Parker Javid · this pageChief Sales and Customer Officer of Curation$460,691

The full Lifecore Biomedical compensation record

free company brief

This page is one person within Lifecore Biomedical's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Lifecore Biomedical proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Lifecore Biomedical's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Parker Javid's compensation dossier · One-time report. No refunds.